Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID‐19 patients

• Main Authors: Bruce M. Hendry (Author), Nina Stafford (Author), Ahran D. Arnold (Author), Arvind Sangwaiya (Author), Vijay Manglam (Author), Stuart D. Rosen (Author), Jayantha Arnold (Author)
• Format: Book
• Published: Wiley, 2020-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract We propose a new hypothesis that the established drug pentoxifylline deserves attention as a potential repurposed therapeutic for COVID‐19. Pentoxifylline is an immunomodulator with anti‐inflammatory properties. It is a nonselective phosphodiesterase inhibitor and through Adenosine A2A Rece...